Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Zebrafish 'able to repair spinal cord injuries'
In a cross section of the adult zebrafish spinal cord, stem cells (green) can be seen to divide (red and/or blue)
In a cross section of the adult zebrafish spinal cord, stem cells (green) can be seen to divide (red and/or blue).

Discovery may offer hope for new therapies in humans
 
Zebrafish are able to heal their own spinal cord injuries by growing new motor neurons, scientists have discovered.

It is hoped this finding could one day lead to new therapies for people with neurodegenerative conditions, such as motor neuron disease.

Damage to motor neurons in humans - either as a result of neurodegeneration or spinal cord injury - is irreversible.

Yet researchers from the University of Edinburgh found that serotonin - best known as the mood boosting hormone - can help zebrafish recover from spinal cord injuries.

They found the hormone is able to send signals to stem cells found in the spinal cord, boosting the growth of new motor neurons.

Using these findings, scientists say they may be able to grow motor neurons in the lab, aiding research into neurodegenerative conditions in humans.

Dr Thomas Becker, from Edinburgh's Centre for Neuroregeneration and the Euan MacDonald Centre for Motor Neuron Disease Research, said: "Understanding how zebrafish are able to repair damaged nerves could one day help us to trigger similar mechanisms in human stem cells.

"Our hope is that this may eventually lead to new treatments for conditions such as motor neuron disease, for which there is no cure."

Image (c) Catherina Becker, University of Edinburgh.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.